MITOCLASS.1 statistics

To access cutting-edge analytics on consensus tools, life science contexts and associated fields, you will need to subscribe to our premium service.


Citations per year

Citations chart

Popular tool citations

chevron_left Mutation entity recognition chevron_right
Popular tools chart

Tool usage distribution map

Tool usage distribution map

Associated diseases

Associated diseases

MITOCLASS.1 specifications


Unique identifier OMICS_16644
Software type Package/Module
Interface Command line interface
Restrictions to use None
Operating system Unix/Linux
Computer skills Advanced
Stability Stable
Maintained Yes



Add your version



  • person_outline toni martin <>

Publication for MITOCLASS.1

MITOCLASS.1 in publication

PMCID: 5811516
PMID: 29479304
DOI: 10.3389/fnins.2018.00061

[…] is conserved in 94.7% of 4,988 eukaryotic (from protists to mammals) sequences (martin-navarro et al., ). pathogenicity predictors, such as mutpred (pereira et al., ), polyphen-2 and mitoclass.1 (martin-navarro et al., ), consider this amino acid substitution as a pathogenic mutation. the m.13094t>c mutation has not been reported in these 37,545 human sequences. […]

To access a full list of publications, you will need to upgrade to our premium service.

MITOCLASS.1 institution(s)
Departamento de Bioquímica, Biología Molecular y Celular, Universidad de Zaragoza, Zaragoza, Spain; Departamento de Informática e Ingeniería de Sistemas, Universidad de Zaragoza, Zaragoza, Spain; Instituto de Investigación en Ingeniería de Aragón (I3A), Universidad de Zaragoza, Zaragoza, Spain; Instituto de Investigación Sanitaria de Aragón (IISA), Universidad de Zaragoza, Zaragoza, Spain; Centro de Investigaciones Biomédicas en Red de Enfermedades Raras (CIBERER), Universidad de Zaragoza, Zaragoza, Spain; Fundación ARAID, Universidad de Zaragoza, Zaragoza, Spain
MITOCLASS.1 funding source(s)
Supported by grants from the Spanish Ministries of Science and Innovation (TIN2011-27479-C04-01, TIN2016-80347-R) and Education (FPU AP2010-1058); Instituto de Salud Carlos III (FIS-PI14/00005 and PI14/00070); Departamento de Ciencia, Tecnología y Universidad del Gobierno de Aragón (Grupos Consolidados B33) and FEDER Funding Program from the European Union.

MITOCLASS.1 reviews

star_border star_border star_border star_border star_border
star star star star star

Be the first to review MITOCLASS.1